Compounds and methods for 18F labeled agents

Details for Australian Patent Application No. 2007294124 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Stellfeld, Timo; Lehmann, Lutz; Brumby, Thomas; Karramkam, Mylene; Ametamey, Simon; Graham, Keith; Srinivasan, Ananth; Sulzle, Detlef

Agent Davies Collison Cave

Pub. Number AU-A-2007294124

PCT Pub. Number WO2008/028688

Priority 07090079.0 23.04.07 EP; 06090166.7 08.09.06 EP

Filing date 7 September 2007

Wipo publication date 13 March 2008

International Classifications

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/04 (2006.01) Preparations containing radioactive substances for use in therapy or testing

C07C 255/58 (2006.01) Carboxylic acid nitriles

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/028688 Priority application(s): WO2008/028688

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007294149-Heteroaryl derivatives as protein kinase inhibitors

2007294123-Use of SNPS for the diagnosis of a pain protective haplotype in the GTP cyclohydrolase 1 gene (GCH1)